 Health Care |
Health Care |
|
|
Nine more drug companies cut deals with White House |
Nine pharmaceutical companies said they have cut "most favored nation" pricing deals with the White House, the largest group the administration has announced to date. |
The companies — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi — all said they'd be dropping prices on some of their products to match what other countries pay.
"What they're doing is so great, and, in the end, they do much more business," President Trump said during an Oval Office press conference. "I think it's going to even out for them."
Friday's announcements follow similar deals with five other companies. Trump in July sent letters to 17 companies, giving them a September deadline to cut prices and make a deal with the White House.
There have been 14 announcements to date; Trump on Friday said they have agreements with the other three companies, but they'll be announced later next year.
"Every president for a generation has promised to reduce drug prices, but … I am the only one of them to ever even think in terms of 'favored nations,'" Trump said.
In exchange for lowering their prices for government programs, the administration has lifted the threat of tariffs and offered the companies other benefits like Food and Drug Administration priority vouchers, which fast-track drug reviews and are worth hundreds of millions of dollars.
Merck, for example, said in a statement Friday it "reached an understanding" with the Department of Commerce to delay Section 232 import tariffs for three years.
But the specific terms of all the agreements are confidential, making it difficult to judge the impact on patients.
Trump praised the drug company CEOs for being willing to negotiate.
"These people really are pioneers," Trump said Friday.
Contrast that with the president's approach to insurance companies: Trump on Friday said he will summon insurance executives to a meeting either in Florida or Washington in the coming weeks to pressure them into lowering premiums.
"I'm going to call in the insurance companies that are making so much money, and they have to make less, a lot less," Trump said. "I'm going to see if they get their price down, to put it very bluntly. And I think that is a very big statement."
Trump's plan to meet with insurance executives comes as enhanced premium subsidies from the Affordable Care Act expire at the end of the year, which will risk raising costs for tens of millions of Americans. |
Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health. |
|
| How policy will be impacting the health care sector this week and beyond: |
|
|
President Trump said Friday he plans to hold a meeting with major insurance companies in the coming days in a bid to pressure them to lower prices for consumers who are set to see premium costs soar when ObamaCare's enhanced subsidies expire at the end of the year. "I’m going to call in the insurance companies that are making so much money, and they have to make less, a lot less," Trump said during an Oval Office announcement … |
| |
|
The Trump administration is planning to announce an overhaul to the childhood immunization schedule early next year, recommending fewer shots and aligning U.S. policy with that of Denmark. A source familiar with the matter told NewsNation correspondent Libbey Dean that a new vaccination schedule to be released next year would recommend fewer shots, "aligning more with Denmark's vaccination schedule" ... |
| |
|
More Americans are listing health care as a top priority with Affordable Care Act subsidies set to expire by the end of the year, according to a new poll. Almost 4 in 10 U.S. adults named health care or health issues as one of the top five issues they want the government to address in an open-ended question presented in a survey backed by The Associated Press-NORC Center for Public Affairs Research. The Friday poll found that … |
| |
|
Branch out with a different read: |
|
|
As GOP blows past ObamaCare deadline, is it too late for a deal? |
Republicans in Congress are jumping off the ObamaCare cliff as they leave Washington without a deal to extend enhanced subsidies for millions of Americans. But the door to a bipartisan deal hasn’t been completely shut, and it may not be too late to reverse looming cost increases if a deal is passed early next year, according to state health care officials. House Speaker Mike Johnson (R-La.), torn between conservatives … |
|
|
Local and state headlines on health care: |
- Amid expiring subsidies and rising premiums, Nevada Health Link refuses to release enrollment data (Nevada Current)
- With ACA subsidies set to expire, Texas Republicans in Congress remain hazy about path forward (Texas Tribune)
- The Mass. board of medicine is meant to protect the public. Instead, it has increasingly protected neglectful doctors (Boston Globe)
|
|
|
Health news we've flagged from other outlets: |
- Whooping cough cases soar as vaccination rates drop (NBC)
- FDA voucher program has become vehicle for political interference in drug review decisions, staffers say (Stat)
- RFK Jr. likely to swap U.S. childhood vaccine schedule for Denmark's (New York Times)
|
|
|
Opinions related to health submitted to The Hill: |
|
|
You're all caught up. See you next week! |
400 N Capitol Street NW Suite 650, Washington, DC 20001 |
Copyright © 1998 - 2025 Nexstar Media Inc. | All Rights Reserved. |
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment